These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 27034386

  • 1. Cytologic Criteria for Mast Cell Tumor Grading in Dogs With Evaluation of Clinical Outcome.
    Camus MS, Priest HL, Koehler JW, Driskell EA, Rakich PM, Ilha MR, Krimer PM.
    Vet Pathol; 2016 Nov; 53(6):1117-1123. PubMed ID: 27034386
    [Abstract] [Full Text] [Related]

  • 2. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
    Vascellari M, Giantin M, Capello K, Carminato A, Morello EM, Vercelli A, Granato A, Buracco P, Dacasto M, Mutinelli F.
    Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
    [Abstract] [Full Text] [Related]

  • 3. Variation among pathologists in histologic grading of canine cutaneous mast cell tumors.
    Northrup NC, Harmon BG, Gieger TL, Brown CA, Carmichael KP, Garcia A, Latimer KS, Munday JS, Rakich PM, Richey LJ, Stedman NL, Cheng AL, Howerth EW.
    J Vet Diagn Invest; 2005 May; 17(3):245-8. PubMed ID: 15945380
    [Abstract] [Full Text] [Related]

  • 4. Histologic grading of canine mast cell tumor: is 2 better than 3?
    Sabattini S, Scarpa F, Berlato D, Bettini G.
    Vet Pathol; 2015 Jan; 52(1):70-3. PubMed ID: 24513799
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs.
    Patnaik AK, Ehler WJ, MacEwen EG.
    Vet Pathol; 1984 Sep; 21(5):469-74. PubMed ID: 6435301
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Proposal of a 2-tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior.
    Kiupel M, Webster JD, Bailey KL, Best S, DeLay J, Detrisac CJ, Fitzgerald SD, Gamble D, Ginn PE, Goldschmidt MH, Hendrick MJ, Howerth EW, Janovitz EB, Langohr I, Lenz SD, Lipscomb TP, Miller MA, Misdorp W, Moroff S, Mullaney TP, Neyens I, O'Toole D, Ramos-Vara J, Scase TJ, Schulman FY, Sledge D, Smedley RC, Smith K, W Snyder P, Southorn E, Stedman NL, Steficek BA, Stromberg PC, Valli VE, Weisbrode SE, Yager J, Heller J, Miller R.
    Vet Pathol; 2011 Jan; 48(1):147-55. PubMed ID: 21062911
    [Abstract] [Full Text] [Related]

  • 9. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
    Kiupel M, Webster JD, Kaneene JB, Miller R, Yuzbasiyan-Gurkan V.
    Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
    Fulcher RP, Ludwig LL, Bergman PJ, Newman SJ, Simpson AM, Patnaik AK.
    J Am Vet Med Assoc; 2006 Jan 15; 228(2):210-5. PubMed ID: 16426187
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors.
    Ginn PE, Fox LE, Brower JC, Gaskin A, Kurzman ID, Kubilis PS.
    Vet Pathol; 2000 Jan 15; 37(1):33-9. PubMed ID: 10643978
    [Abstract] [Full Text] [Related]

  • 12. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
    Kiupel M, Webster JD, Miller RA, Kaneene JB.
    J Vet Med A Physiol Pathol Clin Med; 2005 Aug 15; 52(6):280-6. PubMed ID: 16050909
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors.
    Jaffe MH, Hosgood G, Taylor HW, Kerwin SC, Hedlund CS, Lopez MK, Davidson JR, Miller DM, Paranjpe M.
    Vet Pathol; 2000 Jan 15; 37(1):40-6. PubMed ID: 10643979
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The prognostic value of lymph node metastasis with grade 2 MCTs in dogs: 55 cases (2001-2010).
    Baginski H, Davis G, Bastian RP.
    J Am Anim Hosp Assoc; 2014 Jan 15; 50(2):89-95. PubMed ID: 24446400
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognosis of canine mast cell tumors: a comparison of three methods.
    Simoes JP, Schoning P, Butine M.
    Vet Pathol; 1994 Nov 15; 31(6):637-47. PubMed ID: 7863578
    [Abstract] [Full Text] [Related]

  • 18. Comparison of 2- and 3-category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009-2014).
    Stefanello D, Buracco P, Sabattini S, Finotello R, Giudice C, Grieco V, Iussich S, Tursi M, Scase T, Di Palma S, Bettini G, Ferrari R, Martano M, Gattino F, Marrington M, Mazzola M, Elisabetta Vasconi M, Annoni M, Marconato L.
    J Am Vet Med Assoc; 2015 Apr 01; 246(7):765-9. PubMed ID: 25794126
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cytological grading of canine cutaneous mast cell tumours.
    Scarpa F, Sabattini S, Bettini G.
    Vet Comp Oncol; 2016 Sep 01; 14(3):245-51. PubMed ID: 24717019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.